TITLE

Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA

AUTHOR(S)
Sachdeva, Ashwin; van der Meulen, Jan H.; Emberton, Mark; Cathcart, Paul J.
PUB. DATE
February 2015
SOURCE
BMJ Open;Feb2015, Vol. 5 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
101328394

 

Related Articles

  • A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Morgan, T M; Meng, M V; Cooperberg, M R; Cowan, J E; Weinberg, V; Carroll, P R; Lin, D W // Prostate Cancer & Prostatic Diseases;Jun2014, Vol. 17 Issue 2, p174 

    Background:To determine whether a variable definition of biochemical recurrence (BCR) based on clincopathologic features facilitates early identification of patients likely to suffer from disease progression. The definition of BCR after radical prostatectomy (RP) bears important implications for...

  • Influence of blood prostate specific antigen levels at age 60 on the benefits and harms of prostate cancer screening: population based cohort study. Carlsson, Sigrid; Assel, Melissa; Sjoberg, Daniel; Ulmert, David; Hugosson, Jonas; Lilja, Hans; Vickers, Andrew // BMJ: British Medical Journal;4/26/2014, Vol. 348 Issue 7955, p11 

    The article presents a study on the effect of blood prostate specific antigen levels at the age of 60 on the benefits and dangers of medical screening for prostate cancer. It discusses the participants and the method used in the study, the rate ratio for death from prostate cancer by screening,...

  • Watchful waiting effective for prostate cancer.  // Australian Nursing Journal;Apr97, Vol. 4 Issue 9, p30 

    Studies the favorable survival rate among under-treated patients with early-stage prostate cancer. Age-adjusted mortality rate from prostate cancer in Sweden; Differences in the effects of watchful waiting and early definitive therapy in the incidence of prostate cancer.

  • Managing Advanced Prostate Cancer with Viadurâ„¢ (Leuprolide Acetate Implant). Moul, Judd W.; Civitelli, Karen // Urologic Nursing;Dec2001, Vol. 21 Issue 6, p385 

    Examines the effectiveness of viadur or leuprolide acetate implant in managing advanced prostate cancer. Use of prostatectomy, external beam radiation therapy and brachytherapy to treat localized prostate cancer; Hormone-dependent nature of prostate cancer cells; Definition of advanced prostate...

  • Current Drug Therapy for Prostate Cancer: An Overview. Stewart, Alistair B.; Lwaleed, Bashir A.; Douglas, David A.; Birch, Brian R. // Current Medicinal Chemistry - Anti-Cancer Agents;Nov2005, Vol. 5 Issue 6, p603 

    Prostate cancer is the most common cancer amongst men in the USA and the second most common malignant cause of male death worldwide after lung cancer. The life time risk of having microscopic evidence of prostate cancer for a 50 year old man is 42%. Prostate cancer is thus becoming an...

  • An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? Feletto, E.; Bang, A.; Cole-Clark, D.; Chalasani, V.; Rasiah, K.; Smith, D. // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1677 

    Purpose: To compare prostate cancer incidence and mortality rates in Australia, USA, Canada and England and quantify the gap between observed prostate cancer deaths in Australia and expected deaths, using US mortality rates. Methods: Analysis of age-standardised prostate cancer incidence and...

  • Using PSA kinetics to stratify risk of prostate Ca progression. Lam, John S.; Belldegrun, Arie S. // Urology Times;9/1/2005, Vol. 33 Issue 11, p38 

    Examines the kinetics that regulates prostate-specific antigen (PSA) by researchers from Los Angeles, California. Use of PSA kinetics to stratify risk of prostate cancer progression; Significance of the kinetics in the evaluation and treatment of patients with prostate cancer; Identification of...

  • Quality of life and economic considerations in the management of prostate cancer. Turini, Marco; Redaelli, Alberto; Gramegna, Paola; Radice, Davide // PharmacoEconomics;2003, Vol. 21 Issue 8, p527 

    The purpose of this article was to provide an overview of the morbidity and mortality of prostate cancer, QOL issues and the economic impact of the disease. We searched Medline (from 1990 onwards) for all studies dealing with prostate cancer epidemiology, treatment, screening and staging, and...

  • Metabolic Syndrome in Patients on Androgen Deprivation Therapy for Prostate Cancer as seen at Kilimanjaro Christian Medical Center, Moshi, Tanzania. Nabunwa, G.; Mbwambo, J. S.; Nyongole, O. V.; Nyombi, B.; Mteta, A. K. // East & Central African Journal of Surgery;Jul/Aug2014, Vol. 19 Issue 2, p102 

    Background: Prostate cancer is a frequently diagnosed malignancy in elderly men worldwide. Previously displayed as rare in Africa, but now a common diagnosis and a cause of mortality. Androgen deprivation therapy (ADT) is the main stay of treatment in Africa due to men presenting with advanced...

  • 46. Phase I/II Study of Adenoviral Vector Delivery of HSV-tk Gene and the Intravenous Administration of Ganciclovir in Men with Local Recurrence of Prostate Cancer after Hormonal Therapy. Nasu, Yasutomo; Kaku, Haruki; Ebara, Shin; Saika, Takashi; Kumon, Hiromi; Thompson, Timothy C. // Molecular Therapy;Jun2006, Vol. 13, pS19 

    Background: In previous studies, the efficacy and safety of adenovirus-mediated herpes simplex virus - thymidine kinase gene (Adv.RSV-tk) transduction and ganciclovir(GCV) therapy in an orthotopic mouse model of prostate cancer were demonstrated. (Human Gene Therapy 7:515, 1996.Int.J. Cancer...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics